Growth inhibition of A549 human lung adenocarcinoma cells by L-canavanine is associated with p21/WAF1 induction

被引:9
|
作者
Ding, Y
Matsukawa, Y
Ohtani-Fujita, N
Kato, D
Dao, S
Fujii, T
Naito, Y
Yoshikawa, T
Sakai, T [1 ]
Rosenthal, GA
机构
[1] Kyoto Prefectural Univ Med, Dept Prevent Med, Kamigyo Ku, Kyoto 6028566, Japan
[2] Kyoto Prefectural Univ Med, Dept Surg 2, Kamigyo Ku, Kyoto 6028566, Japan
[3] Kyoto Prefectural Univ Med, Dept Med 1, Kamigyo Ku, Kyoto 6028566, Japan
[4] Univ Kentucky, Lab Biochem Ecol, Lexington, KY 40506 USA
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1999年 / 90卷 / 01期
关键词
L-canavanine; p21/WAF1; p53; RB; cell cycle;
D O I
10.1111/j.1349-7006.1999.tb00667.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
L-Canavanine (CAV) is a higher plant nonprotein amino acid and a potent L-arginine antimetabolite, CAV can inhibit the proliferation of tumor cells in vitro and in vivo, but little is known regarding the molecular mechanisms mediating these effects, We demonstrated that the treatment of human lung adenocarcinoma A549 cells with CAV caused growth inhibition; G1 phase arrest is accompanied by accumulation of an incompletely phosphorylated form of the retinoblastoma protein, whose phosphorylation is necessary for cell cycle progression from G1 to S phase. Zn addition, CAV induces the expression of p53 and subsequent expression of a cyclin-dependent kinase inhibitor, p21/WAF1. The p53-dependent induction of p21/WAF1 and the following dephosphorylation of the retinoblastoma protein by CAV could account for the observed CAV-mediated G1 phase arrest.
引用
收藏
页码:69 / 74
页数:6
相关论文
共 50 条
  • [21] Alterations of p53 and expression of WAF1/p21 in human thyroid tumors
    Zedenius, J
    Larsson, C
    Wallin, G
    Backdahl, M
    Aspenblad, U
    Hoog, A
    Borresen, AL
    Auer, G
    THYROID, 1996, 6 (01) : 1 - 9
  • [22] INHIBITION OF THE GROWTH OF HUMAN PANCREATIC-CANCER CELLS BY THE ARGININE ANTIMETABOLITE L-CANAVANINE - REPLY
    ROSENTHAL, GA
    SWAFFAR, DS
    ANG, CY
    CANCER RESEARCH, 1995, 55 (19) : 4486 - 4487
  • [23] Relationship of p21 (waf1/cip1) and differentiation n chondrosarcoma cells
    Hiraoka, K
    Zenmyo, M
    Komiya, S
    Kawabata, R
    Yokouchi, M
    Suzuki, R
    Hamada, T
    Kato, S
    Nagata, K
    VIRCHOWS ARCHIV, 2002, 440 (03) : 285 - 290
  • [24] Cytostatic effect of TNF alpha on cancer cells is independent of p21(WAF1)
    Shiohara, M
    Gombart, AF
    Berman, JD
    Koike, K
    Komiyama, A
    Koeffler, HP
    ONCOGENE, 1997, 15 (13) : 1605 - 1609
  • [25] p21(WAF1)-derived peptides linked to an internalization peptide inhibit human cancer cell growth
    Bonfanti, M
    Taverna, S
    Salmona, M
    DIncalci, M
    Broggini, M
    CANCER RESEARCH, 1997, 57 (08) : 1442 - 1446
  • [26] The Intestinal Microenvironment Restricts HIV-1 Replication in Human Dendritic Cells Through p21 Cip1/WAF1 Induction
    Cavarelli, Mariangela
    Tolazzi, Monica
    Casuso, Jose Carlos Valle
    Tsilingiri, Katerina
    Fusetti, Bianca
    Cribier, Alexandra
    Benkirane, Monsef
    Rescigno, Maria
    Saez-Cirion, Asier
    Scarlatti, Gabriella
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 316 - 316
  • [27] Pemetrexed-induced ferroptosis in A549 human lung cancer cells and a protective role of p21
    Harada, Mamoru
    Iida, Yuichi
    Hoque, Mahbubul M.
    Kotani, Hitoshi
    CANCER SCIENCE, 2024, 115 : 128 - 128
  • [28] Involvement of p21WAF1/CIP1, pRB, Bax and NF-κB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells
    Kim, YA
    Lee, WH
    Choi, TH
    Rhee, SH
    Park, KY
    Choi, YH
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (04) : 1143 - 1149
  • [29] Induction of cell cycle arrest and p21CIP1/WAF1 expression in human lung cancer cells by isoliquiritigenin
    Li, T
    Satomi, Y
    Katoh, D
    Shimada, J
    Baba, M
    Okuyama, T
    Nishino, H
    Kitamura, N
    CANCER LETTERS, 2004, 207 (01) : 27 - 35
  • [30] The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma
    Dergham, ST
    Dugan, MC
    Joshi, US
    Chen, YC
    Du, W
    Smith, DW
    Arlauskas, P
    Crissman, JD
    Vaitkevicius, VK
    Sarkar, FH
    CANCER, 1997, 80 (03) : 372 - 381